Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome

Frank González, Judi Minium, Neal S. Rote, John P. Kirwan

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Context: Women with polycystic ovary syndrome (PCOS) are often insulin resistant and have chronic low-level inflammation. Objective: The purpose of this study was to determine the effects of hyperglycemia on lipopolysaccharide (LPS)-stimulated TNFα release from mononuclear cells (MNC) in PCOS. Design: The study was designed as a prospective controlled study. Setting: The study was carried out at an academic medical center. Patients: Sixteen reproductive age women with PCOS (eight lean, eight obese) and 14 age-matched controls (eight lean, six obese) participated in the study. Main Outcome Measures: Insulin sensitivity (IS) was derived from a 2-h 75-g oral glucose tolerance test (ISOGTT). Percentage of truncal fat was determined by dual-energy absorptiometry.TNFα release was measured from MNC cultured in the presence of LPS from blood samples drawn fasting and 2 h after glucose ingestion. Results: ISOGTT was lower in women with PCOS compared with controls (3.9 ± 0.4 vs. 6.3 ± 1.0; P <0.03) and was negatively correlated with percentage of truncal fat (r = 0.56; P <0.002). Truncal fat was greater in lean women with PCOS compared with lean controls (29.8 ± 2.6 vs. 23.8 ± 2.5%; P <0.04). The TNFα response was different between obese and lean controls (-96.9 ± 21.2 vs. 24.4 ± 21.6 pg/ml; P <0.03) and obese and lean women with PCOS (-94.1 ± 34.5 vs. 30.4 ± 17.6 pg/ml; P <0.002). Fasting plasma C-reactive protein was elevated (P <0.003) in obese PCOS and obese controls compared with lean controls. Conclusion: An increase in abdominal adiposity and increased TNFα release from MNC after hyperglycemia may contribute to insulin resistance in lean PCOS patients. In contrast, obese PCOS patients have more profound chronic inflammation, and thus may have LPS tolerance that protects them from relatively mild excursions in blood glucose.

Original languageEnglish (US)
Pages (from-to)5336-5342
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume90
Issue number9
DOIs
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Hyperglycemia
Tumor Necrosis Factor-alpha
Lipopolysaccharides
Fats
Insulin
Glucose
Insulin Resistance
Fasting
C-Reactive Protein
Inflammation
Blood Glucose
Blood
Adiposity
Glucose Tolerance Test
Plasmas
Blood Proteins
Cultured Cells
Eating
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome. / González, Frank; Minium, Judi; Rote, Neal S.; Kirwan, John P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 90, No. 9, 09.2005, p. 5336-5342.

Research output: Contribution to journalArticle

González, Frank ; Minium, Judi ; Rote, Neal S. ; Kirwan, John P. / Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome. In: Journal of Clinical Endocrinology and Metabolism. 2005 ; Vol. 90, No. 9. pp. 5336-5342.
@article{dc09eee7f68a4998847165f90c257d19,
title = "Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome",
abstract = "Context: Women with polycystic ovary syndrome (PCOS) are often insulin resistant and have chronic low-level inflammation. Objective: The purpose of this study was to determine the effects of hyperglycemia on lipopolysaccharide (LPS)-stimulated TNFα release from mononuclear cells (MNC) in PCOS. Design: The study was designed as a prospective controlled study. Setting: The study was carried out at an academic medical center. Patients: Sixteen reproductive age women with PCOS (eight lean, eight obese) and 14 age-matched controls (eight lean, six obese) participated in the study. Main Outcome Measures: Insulin sensitivity (IS) was derived from a 2-h 75-g oral glucose tolerance test (ISOGTT). Percentage of truncal fat was determined by dual-energy absorptiometry.TNFα release was measured from MNC cultured in the presence of LPS from blood samples drawn fasting and 2 h after glucose ingestion. Results: ISOGTT was lower in women with PCOS compared with controls (3.9 ± 0.4 vs. 6.3 ± 1.0; P <0.03) and was negatively correlated with percentage of truncal fat (r = 0.56; P <0.002). Truncal fat was greater in lean women with PCOS compared with lean controls (29.8 ± 2.6 vs. 23.8 ± 2.5{\%}; P <0.04). The TNFα response was different between obese and lean controls (-96.9 ± 21.2 vs. 24.4 ± 21.6 pg/ml; P <0.03) and obese and lean women with PCOS (-94.1 ± 34.5 vs. 30.4 ± 17.6 pg/ml; P <0.002). Fasting plasma C-reactive protein was elevated (P <0.003) in obese PCOS and obese controls compared with lean controls. Conclusion: An increase in abdominal adiposity and increased TNFα release from MNC after hyperglycemia may contribute to insulin resistance in lean PCOS patients. In contrast, obese PCOS patients have more profound chronic inflammation, and thus may have LPS tolerance that protects them from relatively mild excursions in blood glucose.",
author = "Frank Gonz{\'a}lez and Judi Minium and Rote, {Neal S.} and Kirwan, {John P.}",
year = "2005",
month = "9",
doi = "10.1210/jc.2005-0694",
language = "English (US)",
volume = "90",
pages = "5336--5342",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome

AU - González, Frank

AU - Minium, Judi

AU - Rote, Neal S.

AU - Kirwan, John P.

PY - 2005/9

Y1 - 2005/9

N2 - Context: Women with polycystic ovary syndrome (PCOS) are often insulin resistant and have chronic low-level inflammation. Objective: The purpose of this study was to determine the effects of hyperglycemia on lipopolysaccharide (LPS)-stimulated TNFα release from mononuclear cells (MNC) in PCOS. Design: The study was designed as a prospective controlled study. Setting: The study was carried out at an academic medical center. Patients: Sixteen reproductive age women with PCOS (eight lean, eight obese) and 14 age-matched controls (eight lean, six obese) participated in the study. Main Outcome Measures: Insulin sensitivity (IS) was derived from a 2-h 75-g oral glucose tolerance test (ISOGTT). Percentage of truncal fat was determined by dual-energy absorptiometry.TNFα release was measured from MNC cultured in the presence of LPS from blood samples drawn fasting and 2 h after glucose ingestion. Results: ISOGTT was lower in women with PCOS compared with controls (3.9 ± 0.4 vs. 6.3 ± 1.0; P <0.03) and was negatively correlated with percentage of truncal fat (r = 0.56; P <0.002). Truncal fat was greater in lean women with PCOS compared with lean controls (29.8 ± 2.6 vs. 23.8 ± 2.5%; P <0.04). The TNFα response was different between obese and lean controls (-96.9 ± 21.2 vs. 24.4 ± 21.6 pg/ml; P <0.03) and obese and lean women with PCOS (-94.1 ± 34.5 vs. 30.4 ± 17.6 pg/ml; P <0.002). Fasting plasma C-reactive protein was elevated (P <0.003) in obese PCOS and obese controls compared with lean controls. Conclusion: An increase in abdominal adiposity and increased TNFα release from MNC after hyperglycemia may contribute to insulin resistance in lean PCOS patients. In contrast, obese PCOS patients have more profound chronic inflammation, and thus may have LPS tolerance that protects them from relatively mild excursions in blood glucose.

AB - Context: Women with polycystic ovary syndrome (PCOS) are often insulin resistant and have chronic low-level inflammation. Objective: The purpose of this study was to determine the effects of hyperglycemia on lipopolysaccharide (LPS)-stimulated TNFα release from mononuclear cells (MNC) in PCOS. Design: The study was designed as a prospective controlled study. Setting: The study was carried out at an academic medical center. Patients: Sixteen reproductive age women with PCOS (eight lean, eight obese) and 14 age-matched controls (eight lean, six obese) participated in the study. Main Outcome Measures: Insulin sensitivity (IS) was derived from a 2-h 75-g oral glucose tolerance test (ISOGTT). Percentage of truncal fat was determined by dual-energy absorptiometry.TNFα release was measured from MNC cultured in the presence of LPS from blood samples drawn fasting and 2 h after glucose ingestion. Results: ISOGTT was lower in women with PCOS compared with controls (3.9 ± 0.4 vs. 6.3 ± 1.0; P <0.03) and was negatively correlated with percentage of truncal fat (r = 0.56; P <0.002). Truncal fat was greater in lean women with PCOS compared with lean controls (29.8 ± 2.6 vs. 23.8 ± 2.5%; P <0.04). The TNFα response was different between obese and lean controls (-96.9 ± 21.2 vs. 24.4 ± 21.6 pg/ml; P <0.03) and obese and lean women with PCOS (-94.1 ± 34.5 vs. 30.4 ± 17.6 pg/ml; P <0.002). Fasting plasma C-reactive protein was elevated (P <0.003) in obese PCOS and obese controls compared with lean controls. Conclusion: An increase in abdominal adiposity and increased TNFα release from MNC after hyperglycemia may contribute to insulin resistance in lean PCOS patients. In contrast, obese PCOS patients have more profound chronic inflammation, and thus may have LPS tolerance that protects them from relatively mild excursions in blood glucose.

UR - http://www.scopus.com/inward/record.url?scp=24344501691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24344501691&partnerID=8YFLogxK

U2 - 10.1210/jc.2005-0694

DO - 10.1210/jc.2005-0694

M3 - Article

C2 - 15985479

AN - SCOPUS:24344501691

VL - 90

SP - 5336

EP - 5342

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -